Blog > Investment Strategies > Take 30% gains on Sinovac Biotech (SVA)
Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

Take 30% gains on Sinovac Biotech (SVA)

Today's Financial News - Posted August 28, 2009

Our three TFN Swine Flu Vaccine plays, Sinovac Biotech Ltd. (AMEX:SVA), Vical Inc. (NASDAQ:VICL), and Dr. Reddy’s Laboratories (NYSE:RDY) are showing profits. But we’re taking profits on only one!

by J. Christoph Amberger

Baltimore, MD — TFN: The market is dragging itself toward positive territory right now… where we’re waiting for it, a champagne cocktail in hand.

A cocktail we intend to pay for with the gains from selling out last week’s swine flu pick Sinovac Biotech Ltd. (AMEX:SVA). You remember, those we picked in TFN Special Report: The Top Swine Flu Vaccine Stocks under $20.

We’re clinging to our other picks:

Vical Inc. (NASDAQ:VICL) — up 21.78% — and Dr. Reddy’s Laboratories (NYSE:RDY) is up a paltry +2.35% (but better than nothing!) Heck they have to wait until someone has actually created that vaccine to take it generic!


Next Article: A chart worth studying: Natural gas vs. crude prices

Related Articles

Posted by J. Christoph Amberger · Filed Under Investment Strategies 

Share this article:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • Google Bookmarks
  • NewsVine
  • StumbleUpon
  • Twitter

 Add to Technorati Favorites | Follow Us on Twitter!

Be the first to leave a reply.

Your comments are welcome